Screener
Nuvation Bio NUVB Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License | $8.5M+136% | $64.72M+1,999% | $26.16M+358% | $5.4M+642% | $3.6M+151% | |
| Product Revenue | $23.2M+2,800% | $18.5M+2,213% | $15.7M— | $7.7M— | $800K— | |
| Research And Development Service Revenue | $2M-9.1% | $700K-63.2% | —— | $1.9M+161% | $2.2M+53.3% | |
| Royalty Revenue | $1.6M+700% | $1.4M+600% | $300K— | $300K— | $200K— | |
| Revenue by Geography | ||||||
| CN | $7.99M+138% | $5.19M+78.8% | $972K-75.6% | $2.18M+3,260% | $3.35M+206% | |
| JP | $504K+109% | $652K+256% | $25.19M+1,361% | $3.21M+385% | $241K-29.1% | |
| US | $23.19M+1,773% | $77.39M— | $15.7M— | $7.72M— | $1.24M— |
FAQ
- How does Nuvation Bio break its business down?
- Nuvation Bio (NUVB) reports revenue by product across 4 parts — License, Product Revenue, Research And Development Service Revenue and Royalty Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Nuvation Bio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Nuvation Bio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
